2-[N-(phenylsulfonyl)tryptophyl]-7-endo-[1,1-(ethylenedioxy)ethyl]isoquinuclidene
Compound with spectra: 1 NMR, and 1 MS (GC)
![2-[N-(phenylsulfonyl)tryptophyl]-7-endo-[1,1-(ethylenedioxy)ethyl]isoquinuclidene](/api/compound/FzP9NadDF0k.png?ph=true&h=300&w=458 "2-[N-(phenylsulfonyl)tryptophyl]-7-endo-[1,1-(ethylenedioxy)ethyl]isoquinuclidene")
| SpectraBase Compound ID | FzP9NadDF0k |
|---|---|
| InChI | InChI=1S/C27H30N2O4S/c1-27(32-15-16-33-27)24-17-20-11-12-26(24)28(18-20)14-13-21-19-29(25-10-6-5-9-23(21)25)34(30,31)22-7-3-2-4-8-22/h2-12,19-20,24,26H,13-18H2,1H3/t20-,24+,26+/m0/s1 |
| InChIKey | JSWNPJKQWBGFCX-HQCZVFHSSA-N |
| Mol Weight | 478.61 g/mol |
| Molecular Formula | C27H30N2O4S |
| Exact Mass | 478.192629 g/mol |
| Enantiomer InChIKey | JSWNPJKQWBGFCX-PSUQPPDWSA-N |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | J-54-2899-15 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,1'-Bis(benzenesulfonyl)-8-bromocoscinamide B
1,1'-Bis(benzenesulfonyl)coscinamide B
3-Methyl-3-(N-sulfonylindol-3'-methyl)-2,3-dihydrobenzofuran
(3E)-1-[2-[1-(benzenesulfonyl)-2-(chloromethyl)-3-indolyl]ethyl]-3-(dimethylhydrazinylidene)-2-piperidinone
N-(1-Naphthalen-1-ylethyl)-2-oxo-2-[1-(toluene-4-sulfonyl)-1H-indol-3-yl]acetamide
(R)-4-Bromo-N-carbobenzyloxy-N-methyl-1-tosyltryptophan Methyl Ester
1-(2-Hydroxy-2-phenylethyl)-2-[1-(phenylsulfonyl)-3-indolyl]-4-methylenepiperidine
1H-Indole, 3-[(4-fluorophenyl)methyl]-1-[(4-methylphenyl)sulfonyl]-4,6-dinitro-
2-Chloro-5-methoxy-4-(N-tosyl-3'-indolyl)pyrimidine
2-[1-(Phenylsulfonyl)-3-indolyl]-4-piperidone Ethylene Acetal
| Title | Journal or Book | Year |
|---|---|---|
| Model studies probing the amino-Claisen rearrangement approach to hydroisoquinoline synthesis. Development of methods for stereocontrolled introduction of reserpine E ring type functionality | The Journal of Organic Chemistry | 1989 |